Article Text

Download PDFPDF

Multicentre trial of naproxen and phenylbutazone in acute gout.
  1. R A Sturge,
  2. J T Scott,
  3. E B Hamilton,
  4. S P Liyanage,
  5. A S Dixon,
  6. J Davies,
  7. C Engler


    Naproxen 750 mg as a single dose followed by 250 mg three times daily has been compared with phenylbutazone 200 mg four times daily for 48 hours followed by 200 mg three times daily for treatment of acute gout in an open study on 41 patients. The drugs were equally effective with few and relatively mild side effects. Naproxen is a useful alternative agent for the treatment of acute gout.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.